Herpangina

Jump to navigation Jump to search

WikiDoc Resources for Herpangina

Articles

Most recent articles on Herpangina

Most cited articles on Herpangina

Review articles on Herpangina

Articles on Herpangina in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Herpangina

Images of Herpangina

Photos of Herpangina

Podcasts & MP3s on Herpangina

Videos on Herpangina

Evidence Based Medicine

Cochrane Collaboration on Herpangina

Bandolier on Herpangina

TRIP on Herpangina

Clinical Trials

Ongoing Trials on Herpangina at Clinical Trials.gov

Trial results on Herpangina

Clinical Trials on Herpangina at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Herpangina

NICE Guidance on Herpangina

NHS PRODIGY Guidance

FDA on Herpangina

CDC on Herpangina

Books

Books on Herpangina

News

Herpangina in the news

Be alerted to news on Herpangina

News trends on Herpangina

Commentary

Blogs on Herpangina

Definitions

Definitions of Herpangina

Patient Resources / Community

Patient resources on Herpangina

Discussion groups on Herpangina

Patient Handouts on Herpangina

Directions to Hospitals Treating Herpangina

Risk calculators and risk factors for Herpangina

Healthcare Provider Resources

Symptoms of Herpangina

Causes & Risk Factors for Herpangina

Diagnostic studies for Herpangina

Treatment of Herpangina

Continuing Medical Education (CME)

CME Programs on Herpangina

International

Herpangina en Espanol

Herpangina en Francais

Business

Herpangina in the Marketplace

Patents on Herpangina

Experimental / Informatics

List of terms related to Herpangina

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Fatimo Biobaku M.B.B.S [2]

Synonyms: Vesicular stomatitis, Acute lymphonodular pharyngitis

Overview

Historical Perspective

The name 'herpangina' was coined by Zahorsky, and he was also the first person to give a full description of the clinical entitity in 1920.[1] The first isolation and description of the coxsackie virus was in 1948 by Dalldorf and Sickles.[1]

Causes

Herpangina is caused by enteroviruses. The majority of herpangina cases are caused by coxsackie A viruses (commonly A1, A2, A6, A8, A10, A16, and A22) but it can also be caused by other enteroviruses such as some serotypes of coxsackie B virus, echovirus and enterovirus 71.[2][3][4]

Pathophysiology

Erythema, vesicles and ulcerating lesions in herpangina
Erythema, vesicles and ulcerating lesions in herpangina

The mode of transmission of enteroviruses is usually via fecal–oral transmission. However, it can also be spread through contact with virus-contaminated oral secretions, vesicular fluid, contaminated surfaces or fomites, and via respiratory droplets.[5][6]

Risk Factors

Differential Diagnosis

The following diseases may mimic herpangina:[2][4]

  • Herpetic gingivostomatitis- This is caused by herpes simplex virus(HSV) infection, and affects the anterior oral cavity. It commonly affects the inner parts of the lips, the buccal mucosa, and the tongue. Gingivitis and cervical lymphadenitis can be seen in HSV infection but these are usually absent in herpangina.
  • Bacterial pharyngitis
  • Tonsillitis
  • Aphthous stomatitis
  • Hand-foot-mouth disease

Epidemiology

Age

Herpangina is seen predominantly in children and summer outbreaks are not uncommon. It occurs more frequently in children between the ages of 3-10yrs.[2][4] Adolescents and young adults are occasionally affected.[4]

Sex

There is no known sex predilection.[2]

Natural History, Complications, Prognosis

Herpangina is a self-limited infection of the upper respiratory tract, and complete resolution generally occurs within 1 week.[2] Complications like meningitis rarely occurs.

Diagnosis

History and Symptoms

The history and symptoms may include the following:[4][2]

  • Sudden fever
  • Sore throat and dysphagia- These can occur several hours(up to 24 hours), before the appearance of the enathem
  • Vomitting
  • Abdominal pain
  • Myalgia
  • Headache
  • Pharyngeal lesions
  • Most patients do not appear severely ill

Physical Examination

Examination of the throat can reveal the following:[4]

  • Erythema
  • Exudate of the tonsils which is usually mild
  • Characteristic enathem- Punctate macule which evolve over a period of 24 hours to 2-4mm erythematous papules which vesiculate, and then centrally ulcerate.
  • The lesions are usually small in number, and evolve rapidly. The lesions are seen more commonly on the soft palate and uvula. The lesions can also be seen on the tonsils, posterior pharyngeal wall and the buccal mucosa.

Laborotory Tests[2]

  • The diagnosis of herpangina is clinical
  • When unsure of the diagnosis, pharyngeal viral and bacterial cultures to exclude HSV infection and streptococcal pharyngitis
  • Approximately 1 week after infection, type-specific antibodies appear in the blood with maximum titer occurring in 3 weeks

Treatment

Herpangina is a self-limited infection, and the treatment comprises the management of the symptoms. This entails:[2]

  • Symptomatic treatment of sore throat with saline gargles, analgesic throat lozenges and liberal oral fluid intake
  • Analgesic medications for pain
  • Antipyretic medications when indicated
  • Avoidance of antiviral and antibacterial medications as symptoms generally resolve within 1 week.

Prevention

References

Template:WH Template:WikiDoc Sources

  1. 1.0 1.1 HOWLETT JG, SOMLO F, KALZ F (1957). "A new syndrome of parotitis with herpangina caused by the Coxsackie virus". Can Med Assoc J. 77 (1): 5–7. PMC 1823836. PMID 13437259.
  2. 2.0 2.1 2.2 2.3 2.4 2.5 2.6 2.7 Ferri, Fred (2017). "Chapter:Herpangina". Ferri's Clinical Advisor 2017. Elsevier. pp. 583–583. ISBN 978-0-3232-8048-8.
  3. Li W, Gao HH, Zhang Q, Liu YJ, Tao R, Cheng YP; et al. (2016). "Large outbreak of herpangina in children caused by enterovirus in summer of 2015 in Hangzhou, China". Sci Rep. 6: 35388. doi:10.1038/srep35388. PMC 5067559. PMID 27752104.
  4. 4.0 4.1 4.2 4.3 4.4 4.5 Durand, Marlene (2015). "Chapter 174:Coxsackieviruses, Echoviruses, and Numbered Enteroviruses(EV-D68)". Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases Updated Edition, Eighth Edition. Elsevier. pp. 2080–2090. ISBN 978-1-4557-4801-3.
  5. Muehlenbachs A, Bhatnagar J, Zaki SR (2015). "Tissue tropism, pathology and pathogenesis of enterovirus infection". J Pathol. 235 (2): 217–28. doi:10.1002/path.4438. PMID 25211036.
  6. Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH (2010). "Virology, epidemiology, pathogenesis, and control of enterovirus 71". Lancet Infect Dis. 10 (11): 778–90. doi:10.1016/S1473-3099(10)70194-8. PMID 20961813.